Literature DB >> 10213554

Isradipine, raised glycosylated haemoglobin, and risk of cardiovascular events.

R P Byington, T E Craven, C D Furberg, M Pahor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10213554     DOI: 10.1016/S0140-6736(05)70455-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Recent advances in the management of hypertension in the elderly.

Authors:  F J Gennari; A S Gennari
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

2.  The effect of carvedilol on blood glucose levels in normal albino rats.

Authors:  Suresha R N; Ashwini V; Pragathi B; Kalabharathi H L; Satish A M; Pushpa V H; Jayanthi M K; Snehalatha P
Journal:  J Clin Diagn Res       Date:  2013-09-10

Review 3.  Is the use of some calcium antagonists linked to cancer? Evidence from recent observational studies.

Authors:  M Pahor; C D Furberg
Journal:  Drugs Aging       Date:  1998-08       Impact factor: 3.923

4.  Calcium channel blockers. The jury is still out on whether they cause heart attacks and suicide.

Authors:  A V Stanton
Journal:  BMJ       Date:  1998-05-16

5.  Controversies surrounding the treatment of the hypertensive patient with diabetes.

Authors:  L M Prisant; R J Louard
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

Review 6.  Treatment of diabetic patients with hypertension.

Authors:  W H Birkenhäger; J A Staessen
Journal:  Curr Hypertens Rep       Date:  1999-06       Impact factor: 5.369

7.  Amlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J).

Authors:  Ryuzo Kawamori; Hiroyuki Daida; Yasushi Tanaka; Katsumi Miyauchi; Akira Kitagawa; Dobun Hayashi; Junji Kishimoto; Shunya Ikeda; Yutaka Imai; Tsutomu Yamazaki
Journal:  BMC Cardiovasc Disord       Date:  2006-10-09       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.